Ceftin (cefuroxime) for early Lyme disease
July 1997
Glaxo is now promoting Ceftin (cefuroxime) for early Lyme disease. It's the first antibiotic to be approved for this use.
But don't get too excited.
Ceftin isn't any more effective than doxycycline...and it costs 10 times more. Three weeks of Ceftin costs over $200.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote